New diagnostic options in hypertrophic cardiomyopathy

Area of Science:

• Cardiology
• Medical Diagnostics
• Genetics

Background:

• Hypertrophic cardiomyopathy (HCM) presents complex pathophysiologic features and clinical manifestations.
• Rapid advancements in understanding HCM's molecular defects are ongoing.
• Genetic screening highlights the importance of the standard electrocardiogram (ECG) for initial HCM assessment.

Purpose of the Study:

• To review recent advancements in diagnostic options for HCM.
• To evaluate the prognostic value of various diagnostic markers in HCM.
• To discuss the evolving role of imaging techniques in HCM management.

Main Methods:

• Literature review of new diagnostic technologies for HCM.
• Analysis of studies on electrocardiogram (ECG), heart rate variability, late potentials, and QT dispersion.
• Evaluation of echocardiography (transthoracic and transesophageal) applications.
• Review of emerging roles for magnetic resonance imaging (MRI) and positron-emission tomography (PET) in HCM.

Main Results:

• Standard ECG remains a valuable initial screening tool for HCM.
• Heart rate variability, late potentials, and QT dispersion are not reliable prognostic markers.
• Measurement of conduction dispersion may identify high risk for sudden cardiac death in HCM.
• Echocardiography offers significant advancements in mitral valve assessment, left ventricular dilatation detection, coronary flow analysis, and intraoperative evaluation.

Conclusions:

• New diagnostic options have significantly improved the elucidation of HCM.
• Conduction dispersion and advanced imaging techniques like echocardiography, MRI, and PET are crucial for risk stratification and management.
• Continued research into molecular defects and diagnostic technologies is essential for advancing HCM care.